ReviewInternational journal of molecular sciences2026

Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes.

Urna Kansakar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.